Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes: [[:Category:PCSK9_inhibitors|PCSK9 inhibitor]] & routes : subcutaneous or transdermal

Use the filters below to narrow your results.

generic:
Evolocumab (1)
brand:
Repatha (1)
classes: (Click arrow to add another value)
mechanism:
None (1)
uses:
'"`UNIQ--vote-0000147C-QINU`"', '"`UNIQ--vote-0000147D-QINU`"', '"`UNIQ--vote-0000147E-QINU`"' (1)
starting dose:
140 mg SC every 2 weeks OR 420 mg SC monthly (3 consecutive injections 5 minutes apart due to volume) (1)
preparations:
140 mg/mL single-use prefilled syringe and SureClick autoinjector; Pushtronex 420 mg/3.5 mL on-body infusor (1)
fda max:
420 mg/month (1)
routes: (Click arrow to add another value)
onset:
LDL reduction ~50-60% from baseline at 1-2 weeks (1)
duration:
2-4 weeks per dose (1)
halflife:
~11-17 days'"`UNIQ--ref-0000147F-QINU`"' (1)
bioavailability:
~72% from SC depot'"`UNIQ--ref-00001480-QINU`"' (1)
pregnancy:
Limited data.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
[[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"